Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia

por Levine, Ross L., Valk, Peter J.M.
Publicado 2019

Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia

por Vonk, Christian M., Al Hinai, Adil S. A., Hanekamp, Diana, Valk, Peter J. M.
Publicado 2021

Positron emission tomography: clinical practice

por Valk, Peter E, Delbeke, Dominique, Bailey, Dale L, Townsend, David W, Maisey, Michael N
Publicado 2006

Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis

por Hellesøy, Monica, Engen, Caroline, Grob, Tim, Löwenberg, Bob, Valk, Peter J. M., Gjertsen, Bjørn T.
Publicado 2021

The effect of oligonucleotide microarray data pre-processing on the analysis of patient-cohort studies

por Verhaak, Roel GW, Staal, Frank JT, Valk, Peter JM, Lowenberg, Bob, Reinders, Marcel JT, de Ridder, Dick
Publicado 2006

Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice

por Kockerols, Camille C.B., Valk, Peter J.M., Levin, Mark-David, Pallisgaard, Niels, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2020

The Antioxidant Protein Peroxiredoxin 4 Is Epigenetically Down Regulated in Acute Promyelocytic Leukemia

por Palande, Karishma K., Beekman, Renee, van der Meeren, Lotte E., Beverloo, H. Berna, Valk, Peter J. M., Touw, Ivo P.
Publicado 2011

A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC

por Brand, Jaap, van Vliet, Martin H, de Best, Leonie, Valk, Peter JM, Viëtor, Henk E, Löwenberg, Bob, van Beers, Erik H
Publicado 2013

A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia

por Niavarani, Ahmadreza, Herold, Tobias, Reyal, Yasmin, Sauerland, Maria C., Buchner, Thomas, Hiddemann, Wolfgang, Bohlander, Stefan K., Valk, Peter J. M., Bonnet, Dominique
Publicado 2016

Azacytidine Treatment for VEXAS Syndrome

por Raaijmakers, Marc H. G. P., Hermans, Maud, Aalbers, Anna, Rijken, Melissa, Dalm, Virgil A. S. H., van Daele, Paul, Valk, Peter J. M.
Publicado 2021

Retroviral Integration Mutagenesis in Mice and Comparative Analysis in Human AML Identify Reduced PTP4A3 Expression as a Prognostic Indicator

por Beekman, Renée, Valkhof, Marijke, Erkeland, Stefan J., Taskesen, Erdogan, Rockova, Veronika, Peeters, Justine K., Valk, Peter J. M., Löwenberg, Bob, Touw, Ivo P.
Publicado 2011

The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome

por Hinai, Adil S.A. Al, Pratcorona, Marta, Grob, Tim, Kavelaars, François G., Bussaglia, Elena, Sanders, Mathijs A., Nomdedeu, Josep, Valk, Peter J.M.
Publicado 2019

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

por Janssen, Luca L.G., Westers, Theresia M., Rovers, Jeroen, Valk, Peter J.M., Cloos, Jacqueline, de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2023

SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels

por Sanders, Mathijs A, Verhaak, Roel GW, Geertsma-Kleinekoort, Wendy MC, Abbas, Saman, Horsman, Sebastiaan, van der Spek, Peter J, Löwenberg, Bob, Valk, Peter JM
Publicado 2008

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

por Engen, Caroline, Hellesøy, Monica, Grob, Tim, Al Hinai, Adil, Brendehaug, Atle, Wergeland, Line, Bedringaas, Siv Lise, Hovland, Randi, Valk, Peter J. M., Gjertsen, Bjørn T.
Publicado 2021

miR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2

por Vandewalle, Virginie, Essaghir, Ahmed, Bollaert, Emeline, Lenglez, Sandrine, Graux, Carlos, Schoemans, Hélène, Saussoy, Pascale, Michaux, Lucienne, Valk, Peter J. M., Demoulin, Jean‐Baptiste, Havelange, Violaine
Publicado 2020

HeatMapper: powerful combined visualization of gene expression profile correlations, genotypes, phenotypes and sample characteristics

por Verhaak, Roel GW, Sanders, Mathijs A, Bijl, Maarten A, Delwel, Ruud, Horsman, Sebastiaan, Moorhouse, Michael J, van der Spek, Peter J, Löwenberg, Bob, Valk, Peter JM
Publicado 2006

P318: LOSS OF SCARNA12 RESULTS IN ABERRANT SPLICING OF TARGET GENES AND DOWNREGULATION OF P53 IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL)

por Verbeek, Martijn, Sanders, Mathijs, Grashof, Dwin, van de Werken, Harmen, Van Zuijen, Iris, Bos, Annemarieke, Bindels, Eric, Hoogenboezem, Remco, Valk, Peter, van der Velden, Vincent, Erkeland, Stefan
Publicado 2023

Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging

por Kallemeijn, Martine J., Kavelaars, François G., van der Klift, Michèle Y., Wolvers-Tettero, Ingrid L. M., Valk, Peter J. M., van Dongen, Jacques J. M., Langerak, Anton W.
Publicado 2018

PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy

por Maru, Bruktawit, Messikommer, Alessandra, Huang, Linhui, Seipel, Katja, Kovecses, Olivia, Valk, Peter J.M., Theocharides, Alexandre P.A., Mercier, Francois E., Pabst, Thomas, McKeague, Maureen, Luedtke, Nathan W.
Publicado 2023